St. Jude Medical (STJ) Tops Q4 EPS by 1c, FY16 EPS Guidance Falls Short
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
St. Jude Medical Reports Fourth Quarter and Full-Year 2015 Results
January 27, 2016 7:15 AM ESTST. PAUL, Minn.--(BUSINESS WIRE)-- St. Jude Medical, Inc. (NYSE: STJ) today reported sales and net earnings for the fourth quarter and full-year ended Jan. 2, 2016.
Fourth quarter 2015 highlights:
Neuromodulation sales increased 9 percent on a constant-currency basis over the fourth quarter of 2014 Thoratec product sales grew 15% on a comparable constant currency basis for the full fourth quarter 2015 Adjusted net earnings per share of $1.02 increased 11 percent on a constant currency basis, compared to the fourth quarter of 2014Fourth... More
